A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)

T. Scott Stroup, Joseph Patrick McEvoy, Kimberly D. Ring, Robert H. Hamer, Lisa M. LaVange, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Abraham M. Nussbaum, Jeffrey A. Lieberman

Research output: Contribution to journal › Article › peer-review

149 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)'. Together they form a unique fingerprint.

Medicine & Life Sciences